IL1B and Insulin resistance: In obesity, the release of FFA and cytokines (IL-6, IL-1β, PAI-1, TNF-α) from VAT into the portal vein may contribute to hepatic insulin resistance, hepatic triglyceride deposition, and NAFLD—the portal hypothesis.